Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Pneumococcal Vaccines/administration & dosage"'
Autor:
Herbert, Jenny A, Kay, Emily J, Faustini, Sian E, Richter, Alex, Abouelhadid, Sherif, Cuccui, Jon, Wren, Brendan, Mitchell, Timothy J
Publikováno v:
Vaccine
Herbert, J A, Kay, E J, Faustini, S E, Richter, A, Abouelhadid, S, Cuccui, J, Wren, B & Mitchell, T J 2018, ' Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine ', Vaccine, vol. 36, no. 26, pp. 3809-3819 . https://doi.org/10.1016/j.vaccine.2018.05.036
Herbert, J A, Kay, E J, Faustini, S E, Richter, A, Abouelhadid, S, Cuccui, J, Wren, B & Mitchell, T J 2018, ' Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine ', Vaccine, vol. 36, no. 26, pp. 3809-3819 . https://doi.org/10.1016/j.vaccine.2018.05.036
Highlights • Pneumococcal glycoconjugate vaccines produced in E. coli are protective in mice. • Protection correlates with opsonic antibody levels. • This is a cheaper way to produce conjugate vaccines.
Streptococcus pneumoniae is the lead
Streptococcus pneumoniae is the lead
Autor:
Pittet, Laure, Verolet, Charlotte, Michetti, Pierre, Girardin, Marc, Juillerat, Pascal, Mottet, Christian, Maillard, Michel H, Siegrist, Claire-Anne, Posfay Barbe, Klara, Swiss Inflammatory Bowel Disease Cohort Study Group
Publikováno v:
American Journal of Gastroenterology, Vol. 114, No 7 (2019) pp. 1130-1141
INTRODUCTION Patients with inflammatory bowel disease (IBD) are predisposed to pneumococcal infections due to their underlying disease and iatrogenic immunosuppression. Vaccination with the 13-valent pneumococcal conjugated vaccine (PCV13) is recomme
Autor:
Timothy J. Mitchell, Giles Edwards, Karen E. Lamb, Jim McMenamin, Andrew Smith, David G. Greenhalgh, Johanna M.C. Jefferies, Stefan Flasche, Chris Robertson, Donald Inverarity, Barbara Denham, Eisin McDonald, Matthew A. Diggle, Stuart C. Clarke
Publikováno v:
Vaccine
Vaccine, 2014, 32 (34), pp.4356-63. ⟨10.1016/j.vaccine.2013.05.079⟩
Vaccine, 2014, 32 (34), pp.4356-63. ⟨10.1016/j.vaccine.2013.05.079⟩
Lamb, Karen E Flasche, Stefan Diggle, Mathew Inverarity, Donald Greenhalgh, David Jefferies, Johanna M Smith, Andrew Edwards, Giles F S Denham, Barbara McMenamin, Jim McDonald, Eisin Mitchell, Tim J Clarke, Stuart C Robertson, Chris eng Netherlands 2
Autor:
George A. Syrogiannopoulos, Myint Tin Tin Htar, António Brito-Avô, Filippo Ansaldi, Federico Martinón-Torres, Markus Knuf, Alain Gervaix, David Tuerlinckx, Chiara Azzari
Publikováno v:
Clinical Therapeutics, Vol. 36, No 5 (2014) pp. 802-12.e1
Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d882ac0d89a27309382aeba78f9257
https://archive-ouverte.unige.ch/unige:55173
https://archive-ouverte.unige.ch/unige:55173
Publikováno v:
Current Opinion in Infectious Diseases, Vol. 25, No 3 (2012) pp. 292-303
Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These vaccines are also recommended for those at increased risk of pneumococcal infection and to provide optimal serotype coverage to those at increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::476ab2da142b0ad82acf56297b14c695
https://archive-ouverte.unige.ch/unige:31385
https://archive-ouverte.unige.ch/unige:31385
Publikováno v:
Revue Médicale Suisse, vol. 6, no. 245, pp. 798-803
Some chronic diseases--like renal failure, liver insufficiency, chronic lung disease, cardiac involvement, diabetes mellitus, asplenia--present limited defects of the immune system and/or a higher risk of infection; therefore, patients with such path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::82d33d1ccbc3243da521230c4f16fa7c
https://serval.unil.ch/notice/serval:BIB_7AE570545379
https://serval.unil.ch/notice/serval:BIB_7AE570545379
Publikováno v:
The Journal of Infectious Diseases, Vol. 201, No 10 (2010) pp. 1570-1579
BACKGROUND: The antibody response to pneumococcal conjugate vaccines (PCVs) in infants is variable. Factors responsible for this variability have not been fully elucidated. The objective of this study was to investigate whether pneumococcal carriage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14dec900846adb46993db22e5f270d84
https://archive-ouverte.unige.ch/unige:20869
https://archive-ouverte.unige.ch/unige:20869
Autor:
Jean-Pierre Michel
Publikováno v:
Expert Review of Vaccines, Vol. 9, No 3 Suppl (2010) pp. 7-10
There is a high burden of infectious diseases in the older population, which is associated with increased morbidity and mortality compared with younger age groups. Too many of these diseases are vaccine preventable yet there is a low vaccine coverage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7866e25ddaaa396c185c300465396235
https://archive-ouverte.unige.ch/unige:20522
https://archive-ouverte.unige.ch/unige:20522
Autor:
Claire-Anne Siegrist, David Goldblatt, Andrew M. Prentice, Lars Å. Hanson, Anthony J. C. Fulford, Andrew Collinson, Sophie E. Moore, Fehmida Jalil
Publikováno v:
Tropical Medicine & International Health, Vol. 11, No 10 (2006) pp. 1529-41
Objective To explore the relationship between calendar month of administration and antibody (Ab) response to vaccination in subjects from The Gambia and Pakistan, two countries with distinct patterns of seasonality. Methods Three cohorts were investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c03b4304f1d7a8c1de2d28f531697a
https://archive-ouverte.unige.ch/unige:72876
https://archive-ouverte.unige.ch/unige:72876
Autor:
Stefania P. Bjarnarson, Dominique Schulz, Claire-Anne Siegrist, Emanuelle Trannoy, Håvard Jakobsen, Ingileif Jonsdottir, Solveig Hannesdottir
Publikováno v:
European Journal of Immunology, Vol. 36, No 2 (2006) pp. 287-95
Immunization with a tetanus-protein (TT) pneumococcal polysaccharide (PPS) conjugate vaccine (Pnc1-TT) induces protective immunity against lethal pneumococcal infections in neonatal and infant mice, but anti-PPS IgG response and protective efficacy i